Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study.

Presse/Média: Research

Périodesept. 11 2023 → sept. 12 2023

Couverture média

3

Couverture média

  • Titre-Sona s THT Cancer Therapy to be assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study
    Nom du médiaM2 PressWIRE
    Pays/TerritoireUnited States
    Date9/12/23
    PersonnesCarman Anthony Giacomantonio
  • Titre-Sona s THT Cancer Therapy to be assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study
    Nom du médiaENP Newswire
    Pays/TerritoireUnited Kingdom
    Date9/12/23
    PersonnesCarman Anthony Giacomantonio
  • TitreSona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study.
    Nom du médiaFinancial News Releases
    Pays/TerritoireCanada
    Date9/11/23
    PersonnesCarman Anthony Giacomantonio